Drug maker, Pfizer Inc., initiated a recall of Lipitor (atorvastatin) in August due to complaints of an uncharacteristic “musty odor.” The recall however only became public this week.

The “musty odor” found in its cholesterol fighting drug first reported in July and to date a total of 191,000 bottles of the branded drug distributed in the U.S. and Canada have been recalled.

The recall, which is ongoing, has been monitored by the Food and Drug Administration (FDA)."Chemical Contamination: complaints of an uncharacteristic odor identified as 2, 4, 6 tribromoanisole,” were on the FDA website as the reason for the products recall.

According to Pfizer spokesperson in a statement, the odor issue is not likely to cause adverse health consequences for patients.The New York based company is working with the bottle supplier to determine the cause of the odor.

The lots included in the recall were 0855020, 0819020, 0842020, 0843020, 0854020.

The expiration date for these lots was January 2013.